Attention Deficit/Hyperactivity Disorder: Are We Fostering Overdiagnosis?
There has been a growing restlessness among professionals and parents about the diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). It is estimated that ADHD is occurring in as many as one out of 10 school-age children and 1 out of 20 adults. The rapidly growing use of stimulants (such as Ritalin) for children with ADHD has raised serious concerns. It is also worth special mention that the production of Ritalin has increased 500%. Many professionals think that the excessive use of stimulants reflects our keen desire for a “quick fix.” Parents have serious concerns regarding possible side effects. Some of the side effects of stimulants are insomnia, reduced appetite, suppressed growth, and suicidal thoughts, and they have long-range health implications. A critical review about the diagnosis and treatment of ADHD is vital to understanding the unsettled issues that have generated heated debate among professionals.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).